Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (18 quarters reported)
$1.77B in Q1 2022 → $2.8B now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Medline Inc | 100.0% | Trimmed 18% | 70,874,326 | $2.8B |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 12, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Medline Inc | Trimmed | −15,599,171 | −$615M | 100.0% |
quarter ended March 31, 2026 · filed May 11, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Medline Inc | Trimmed | −13,040,572 | −$580M | 100.0% |
quarter ended December 31, 2025 · filed February 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Medline Inc | New | +99,514,069 | +$4.18B | 100.0% |
| N None | Exited | +0 | — | — |
quarter ended September 30, 2025 · filed November 12, 2025
No position changes this quarter.
quarter ended June 30, 2025 · filed August 12, 2025
No position changes this quarter.
quarter ended March 31, 2025 · filed May 13, 2025
No position changes this quarter.
quarter ended December 31, 2024 · filed February 12, 2025
No position changes this quarter.
quarter ended September 30, 2024 · filed November 13, 2024
No position changes this quarter.
Loading...